Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 2
1(25.0%)
4Total
N/A(3)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07373782Phase 2Recruiting

Continuous Positive Airway Pressure (CPAP) Assisted Radiotherapy in Breast Cancer

Role: collaborator

NCT02796534Completed

Prevalence of Obstructive Sleep Apnea Syndrome in Type 1 Diabetic Patients Treated With Insulin Pump (At1Home)

Role: collaborator

NCT05664035Not Yet Recruiting

SPAD in Adult Patients

Role: collaborator

NCT04939766Not ApplicableUnknown

Impact of the Use of a Closed-loop Insulin Therapy on the Burden of the Diabetes and the Quality of Life

Role: lead

NCT03592108Not ApplicableCompleted

Benefit of Cheyne-Stokes Respiration Remote Monitoring in CPAP-treated Patients With Obstructive Sleep Apnea to Detect Early Events of Heart Failure.

Role: collaborator

NCT03478137Not ApplicableUnknown

Obstructive Sleep Apnea, CPAP Treatment & Cognitive Ability in HIV

Role: collaborator

All 6 trials loaded